Business Description
ACI Formulations Ltd
ISIN : BD0480ACIFL4
Description
ACI Formulations Ltd is an agricultural chemicals manufacturer. The principal activities of the company are manufacturing and marketing a number of agrochemical and consumer products. The company has structured its operations into the following business segments - Crop Care and Public Health segment, which manufactures and sell crop care and public health products; Mosquito Coil segment is engaged in the manufacturing and selling of mosquito coil products; the Aerosol segment is engaged in the manufacturing and selling aerosol and air freshener products; and Paint segment which manufactures and sells paint products. It derives key revenue from the Crop Care and Public Health segment.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.44 | |||||
Debt-to-Equity | 0.97 | |||||
Debt-to-EBITDA | 4.62 | |||||
Interest Coverage | 2.15 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.22 | |||||
Beneish M-Score | -2.62 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.1 | |||||
3-Year EBITDA Growth Rate | 14.1 | |||||
3-Year EPS without NRI Growth Rate | 36.3 | |||||
3-Year Book Growth Rate | 8.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30.02 | |||||
9-Day RSI | 37.86 | |||||
14-Day RSI | 43.57 | |||||
6-1 Month Momentum % | -14.67 | |||||
12-1 Month Momentum % | -24.58 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.24 | |||||
Quick Ratio | 0.94 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 144.35 | |||||
Days Sales Outstanding | 105.31 | |||||
Days Payable | 12.96 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.07 | |||||
Dividend Payout Ratio | 0.42 | |||||
3-Year Dividend Growth Rate | -9.1 | |||||
Forward Dividend Yield % | 2.07 | |||||
5-Year Yield-on-Cost % | 2.72 | |||||
Shareholder Yield % | 8.06 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 27.72 | |||||
Operating Margin % | 11.38 | |||||
Net Margin % | 5.69 | |||||
FCF Margin % | 16.22 | |||||
ROE % | 8.96 | |||||
ROA % | 4.03 | |||||
ROIC % | 6.96 | |||||
ROC (Joel Greenblatt) % | 12.34 | |||||
ROCE % | 18.61 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 20.21 | |||||
PE Ratio without NRI | 20.21 | |||||
Shiller PE Ratio | 23.64 | |||||
Price-to-Owner-Earnings | 6.97 | |||||
PEG Ratio | 3.16 | |||||
PS Ratio | 1.15 | |||||
PB Ratio | 1.77 | |||||
Price-to-Tangible-Book | 1.77 | |||||
Price-to-Free-Cash-Flow | 7.09 | |||||
Price-to-Operating-Cash-Flow | 6 | |||||
EV-to-EBIT | 13.77 | |||||
EV-to-EBITDA | 12.85 | |||||
EV-to-Revenue | 1.76 | |||||
EV-to-FCF | 10.98 | |||||
Price-to-Projected-FCF | 1.17 | |||||
Price-to-DCF (Earnings Based) | 1.75 | |||||
Price-to-DCF (FCF Based) | 0.61 | |||||
Price-to-Median-PS-Value | 0.66 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.05 | |||||
Price-to-Graham-Number | 1.26 | |||||
Price-to-Net-Current-Asset-Value | 9.03 | |||||
Earnings Yield (Greenblatt) % | 7.26 | |||||
FCF Yield % | 14.11 | |||||
Forward Rate of Return (Yacktman) % | 15.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ACI Formulations Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil BDT) | 4,974.823 | ||
EPS (TTM) (BDT) | 5.988 | ||
Beta | 0 | ||
Volatility % | 14.76 | ||
14-Day RSI | 43.57 | ||
14-Day ATR (BDT) | 2.825273 | ||
20-Day SMA (BDT) | 125.66 | ||
12-1 Month Momentum % | -24.58 | ||
52-Week Range (BDT) | 107.5 - 155 | ||
Shares Outstanding (Mil) | 47.25 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ACI Formulations Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ACI Formulations Ltd Stock Events
Event | Date | Price(BDT) | ||
---|---|---|---|---|
No Event Data |
ACI Formulations Ltd Frequently Asked Questions
What is ACI Formulations Ltd(DHA:ACIFORMULA)'s stock price today?
The current price of DHA:ACIFORMULA is BDT121.00. The 52 week high of DHA:ACIFORMULA is BDT155.00 and 52 week low is BDT107.50.
When is next earnings date of ACI Formulations Ltd(DHA:ACIFORMULA)?
The next earnings date of ACI Formulations Ltd(DHA:ACIFORMULA) is .
Does ACI Formulations Ltd(DHA:ACIFORMULA) pay dividends? If so, how much?
The Dividend Yield %  of ACI Formulations Ltd(DHA:ACIFORMULA) is 2.07% (As of Today), Highest Dividend Payout Ratio of ACI Formulations Ltd(DHA:ACIFORMULA) was 1.7. The lowest was 0.34. And the median was 0.58. The  Forward Dividend Yield % of ACI Formulations Ltd(DHA:ACIFORMULA) is 2.07%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |